Summary & Overview
HCPCS Q4172: Puraply (per square centimeter)
HCPCS Level II code Q4172 designates Puraply or Puraply AM billed per square centimeter, a biologic skin substitute used in topical wound management. Nationally, skin substitutes are a significant component of advanced wound care, affecting utilization patterns, coverage determinations, and cost-management strategies for chronic and acute wounds. Understanding this code is important for providers, billing teams, and payers involved in wound care delivery and reimbursement.
Key payers covered in this overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a compact briefing on clinical context (use as a per-square-centimeter biological graft for wound treatment), typical sites of service (outpatient wound clinics, physician offices, hospital outpatient departments, and home health), and where coverage considerations commonly arise. The full publication provides benchmarks on utilization and reimbursement (when available), summaries of policy language and prior authorization trends, and operational guidance for accurate coding and documentation.
This summary is intended for a national audience seeking a clear, practical reference to HCPCS Level II code Q4172 and its role in advanced wound-care billing and coverage discussions. Data not available in the input are noted within the detailed sections.
Billing Code Overview
HCPCS Level II code Q4172 describes Puraply or Puraply AM, billed per square centimeter. This code represents a biologic wound care product supplied and charged by surface area.
-
Service type: Wound care product application/supply (biologic graft/skin substitute)
-
Typical site of service: Outpatient wound care clinics, physician offices, hospital outpatient departments, and home health settings where topical biologic grafts are applied to skin wounds
Data not available in the input for modifiers, associated taxonomies, ICD-10 diagnoses, and related codes.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with a full-thickness or partial-thickness skin loss from a chronic wound such as a diabetic foot ulcer, venous stasis ulcer, pressure injury, or surgical dehiscence. Puraply or Puraply AM (a collagen/alginate wound dressing provided and billed per square centimeter under Q4172) is applied in an outpatient wound care clinic, ambulatory surgery center, or inpatient bedside setting by a wound care nurse or physician. The clinical workflow includes wound assessment (size, depth, presence of infection, perfusion), cleansing and debridement as indicated, measurement of wound area in square centimeters to determine units of Q4172, application of the dressing to the wound bed, securing with secondary dressings, and documentation of wound characteristics, product lot and quantity (square centimeters), and post-application instructions. Typical follow-up occurs in a wound clinic within 1–2 weeks to assess for granulation and dressing changes, with additional applications billed as needed based on wound size and clinical response.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management service by the same physician on the same day | Use when a separate E/M visit is performed the same day as application and meets E/M documentation requirements. |